Cagent Vascular
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease
$41MSeries D
Role not disclosedUV
U.S. Venture Partners (USVP)
Activity from announced rounds
Activity in this selection359-capital-14e8f1ad
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $121.5M 3 disclosed · full round size, not this investor’s share